25th WONCA Europe Conference,Berlin,Germany 

24 Juni– 27 Juni 2020

Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin

54. DEGAM-Kongress für Allgemeinmedizin und Familienmedizin ist integriert in 25. WONCA Europe Conference 2020


Grundwerte der Allgemeinmedizin: Gefahren und Chancen 

Core Values of Family Medicine: Threats and Opportunities


Read more about the event

About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, is Certified Advisor of Acarix.

For more information, please visit